Robert Landewé - Dissemin

Language
Login

All papers authored by Robert Landewé

This paper is made freely available by the publisher.

2022 Rosalinde Stal

ORCID

, Xenofon Baraliakos

ORCID

, Désirée van der Heijde

ORCID

, Floris van Gaalen

ORCID

ORCID

, Rosaline van den Berg, Monique Reijnierse, Juergen Braun

ORCID

, Robert Landewé

ORCID

, Alexandre Sepriano

ORCID

Role of vertebral corner inflammation and fat deposition on MRI on syndesmophyte development detected on whole spine low-dose CT scan in radiographic axial spondyloarthritis

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Robert Bm Landewé

ORCID

, Juergen Braun

ORCID

Response to: Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’ by Braun and Landewé

Upload

This paper was not found in any repository, but could be made available legally by the author.

2021 Juergen Braun

ORCID

, Robert Bm Landewé

ORCID

Response to: Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physicianreported spondylitis’?’ by Braun and Landewe

Upload

This paper was not found in any repository, but could be made available legally by the author.

Juergen Braun

ORCID

, Robert Bm Landewé

ORCID

No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Anne Boel

ORCID

, Victoria Navarro-Compán

ORCID

, Annelies Boonen

ORCID

ORCID

ORCID

, Maxime Dougados

ORCID

, Robert Landewé

ORCID

, Désirée van der Heijde

ORCID

Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey

Upload

This paper was not found in any repository, but could be made available legally by the author.

Robert Bm Landewé

ORCID

ORCID

, Rémy L. M. Mostard

Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study’’ by Klopfenstein et al

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Ricardo J. O. Ferreira

ORCID

, Robert B. M. Landewé

ORCID

, José A. P. da Silva

ORCID

Definition of Treatment Targets in Rheumatoid Arthritis: Is It Time for Reappraisal?

Upload

This paper was not found in any repository, but could be made available legally by the author.

Marlou T. H. F. Janssen

ORCID

ORCID

, Robert B. M. Landewé

ORCID

, César Magro-Checa, Rémy L. M. Mostard

Antibody response to SARS-CoV-2 in patients receiving glucocorticoids with or without tocilizumab for COVID-19-associated hyperinflammation

Upload

This paper was not found in any repository, but could be made available legally by the author.

Robert Bm Landewé

ORCID

, Lianne S. Gensler, Denis Poddubnyy

ORCID

, Proton Rahman, Maja Hojnik, Xiaoqi Li, Soyi Liu Leage, David Adams, Hilde Carlier, Filip Van den Bosch

ORCID

Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y)

Upload

This paper was not found in any repository, but could be made available legally by the author.

Sofia Ramiro

ORCID

, Rémy L. M. Mostard, Robert B. M. Landewé

ORCID

Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by Kaklamanos et al

Upload

This paper is made freely available by the publisher.

Robert B. M. Landewé

ORCID

, Sofia Ramiro, Rémy L. M. Mostard

COVID-19-induced hyperinflammation, immunosuppression, recovery and survival: how causal inference may help draw robust conclusions

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Sofia Ramiro

ORCID

, Rémy L. M. Mostard, Robert B. M. Landewé

ORCID

Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by De Santis et al

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Peter C. Taylor

ORCID

, Désirée van der Heijde

ORCID

, Robert Landewé

ORCID

, Shannon McCue, Sue Cheng, Annelies Boonen

ORCID

A phase III randomized study of apremilast, an oral phosphodiesterase 4 inhibitor, for active ankylosing spondylitis

Upload

This paper was not found in any repository, but could be made available legally by the author.

Sofia Ramiro

ORCID

, Rémy L. M. Mostard, Robert B. M. Landewé

ORCID

Response to: ’Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by Charles

Upload

This paper was not found in any repository, but could be made available legally by the author.

Bernard Combe

ORCID

, Alan Kivitz, Yoshiya Tanaka

ORCID

, Désirée van der Heijde

ORCID

, J. Abraham Simon, Herbert S. B. Baraf, Uma Kumar

ORCID

, Franziska Matzkies, Beatrix Bartok, Lei Ye, Ying Guo, Chantal Tasset, John S. Sundy, Angelika Jahreis, Mark C. Genovese and 5 other authors

Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Félicie Costantino

ORCID

, Loreto Carmona

ORCID

, Maarten Boers, Marina Backhaus, Peter V. Balint, George A. Bruyn

ORCID

, Robin Christensen, Philip G. Conaghan

ORCID

, Ricardo J. O. Ferreira

ORCID

, Juan Luis Garrido-Castro

ORCID

, Francis Guillemin, Hilde Berner Hammer

ORCID

, Désirée van der Heijde

ORCID

, Annamaria Iagnocco, Marion C. Kortekaas

ORCID

and 8 other authors

EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs)

Upload

This paper was not found in any repository, but could be made available legally by the author.

René Westhovens

ORCID

, William F. C. Rigby, Désirée van der Heijde

ORCID

, Daniel W. T. Ching, William Stohl, Jonathan Kay

ORCID

, Arvind Chopra, Beatrix Bartok, Franziska Matzkies, Zhaoyu Yin, Ying Guo, Chantal Tasset, John S. Sundy, Angelika Jahreis, Neelufar Mozaffarian and 4 other authors

Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

2020 Sofia Ramiro

ORCID

, Rémy Mostard, Robert Bm Landewé

ORCID

Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study’’ by Calvo-Aranda et al

Upload

This paper was not found in any repository, but could be made available legally by the author.

Robert B. M. Landewé

ORCID

, Désirée van der Heijde

ORCID

Use of multidimensional composite scores in rheumatology: parsimony versus subtlety

Upload

This paper was not found in any repository, but could be made available legally by the author.

Sofia Ramiro

ORCID

, Robert B. M. Landewé

ORCID

, Rémy Mostard

Response to ‘Neither earlier not late tocilizumab improved outcomes in the intensive care unit patients with COVID-19 in a retrospective cohort study’ by Moiseev et al

Upload

Missing publications? Search for publications with a matching author name.